CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for tough head and neck cancers
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 adults with advanced head and neck cancer that had spread or come back. The goal was to see if the combo could shrink tumors or slow the disease. Patients were grouped based on whether they had tried…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 09:59 UTC
-
Real-World study shows how cemiplimab fights advanced skin cancer
Disease control CompletedThis study looked at how well the drug cemiplimab works for people with advanced skin cancers (squamous cell or basal cell carcinoma) in real-world settings, not just in controlled trials. Researchers tracked 287 patients to measure tumor shrinkage, survival, side effects, and qu…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:48 UTC
-
New drug shrinks skin cancer before surgery in early trial
Disease control CompletedThis study tested a drug called cemiplimab given before surgery to people with stage II to IV cutaneous squamous cell carcinoma (a type of skin cancer). The goal was to see if the drug could eliminate or shrink the tumor before surgery. 79 participants received the treatment, and…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New drug combo shows promise against tough cancers
Disease control CompletedThis study tested a new drug combination (MK-4280A) in people with certain skin cancers (cutaneous squamous cell carcinoma) or endometrial cancer. The goal was to see if the treatment could shrink or eliminate tumors. 163 participants received either the combination or a standard…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Skin cancer injection shows promise in early trial
Disease control CompletedThis early-phase study tested an experimental drug called cemiplimab, injected directly into skin tumors before surgery. The goal was to see if it is safe and how well it shrinks two types of skin cancer: squamous cell carcinoma and basal cell carcinoma. 97 adults with recurrent,…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New study asks skin cancer patients: are you happy with your care?
Knowledge-focused CompletedThis study looked at how people with a serious type of skin cancer on the head or neck feel about their treatment decisions, quality of life, and satisfaction with care. Researchers asked 78 patients to fill out questionnaires about their health, worries, and how supported they f…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC